scispace - formally typeset
J

Jin Zhong

Researcher at Chinese Academy of Sciences

Publications -  172
Citations -  7453

Jin Zhong is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Hepatitis C virus & Virus. The author has an hindex of 34, co-authored 149 publications receiving 6352 citations. Previous affiliations of Jin Zhong include Scripps Research Institute & ShanghaiTech University.

Papers
More filters
Journal ArticleDOI

Hepatitis C virus NS3/4A protease blocks IL‐28 production

TL;DR: It is demonstrated that IL‐28 (IFN‐λ 2/3) IFN production, similar to type I IFN, represents a primary and direct host response to HCV genomic RNA transfection and it is shown that HCV infection can inhibit IL‐ 28 expression, and that the viral NS3/4A protease activity was responsible for this inhibitory effect.
Journal ArticleDOI

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

TL;DR: The data indicated that apoE expression level in uninfected cells is important for high permissiveness to HCV infection and suggested that exchangeable apolipoproteins reach a natural equilibrium between HCV LVPs and lipoprotein particles, which provides a new perspective to the understanding of the heterogeneity of HCVLVPs in composition.
Journal ArticleDOI

Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika.

TL;DR: Nitazoxanides and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and it is identified that they exerts antiviral effect possibly by targeting the viral postattachment step.
Journal ArticleDOI

A Nanoparticle-Based Hepatitis C Virus Vaccine With Enhanced Potency.

TL;DR: This work designed and produced a fusion protein (sE2-Ferritin) comprising sE2 and a Ferritin unit in Drosophila S2 cells, which self-assembled into a nanoparticle with sE 2 displayed on the surface, providing a new possibility to control HCV.
Journal ArticleDOI

Inhibition of hepatitis C virus infection by polyoxometalates.

TL;DR: It is demonstrated that POM-12 had no effect on the vesicular stomatitis virus infection while had weak inhibitory activity against the influenza virus infection.